Modulation of cathelicidin and defensins by histone deacetylase inhibitors: A potential treatment for multi-drug resistant infectious diseases.

Abstract

Infectious diseases are an important growing public health problem, which perspective has worsened due to the increasing number of drug-resistant strains in the last few years. Although diverse solutions have been proposed, one viable solution could be the use of immune system modulators. The induction of the immune response can be increased by histone deacetylase inhibitors (iHDAC), which in turn modulate the chromatin and increase the activation of different cellular pathways and nuclear factors such as STAT3, HIF-1α NF-kB, C/EBPα and, AP-1. These pathways are capable to promote several immune response-related molecules including those with antimicrobial properties such as antimicrobial peptides (AMPs) that lead to the elimination of pathogens including multi drug-resistant strains.

• Authors: Adrián Rodríguez-Carlos, Yolanda M Jacobo-Delgado, Alan O Santos-Mena, Bruno Rivas-Santiago
• Journal: Peptides (Peptides) Vol. 140 Pg. 170527 (06 2021) ISSN: 1873-5169 [Electronic] United States
• PMID: 33744370 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2021 Elsevier Inc. All rights reserved.

Chemical References

• Anti-Infective Agents
• Cathelicidins
• Defensins
• Histone Deacetylase Inhibitors

Topics

• Animals
• Anti-Infective Agents (pharmacology)
• Cathelicidins (metabolism)
• Communicable Diseases (drug therapy, microbiology, pathology)
• Defensins (metabolism)
• Drug Resistance, Multiple
• Histone Deacetylase Inhibitors (pharmacology)
• Humans